What is he best known for?
The fields of study he is best known for:
- Gene
- Internal medicine
- Malaria
His primary areas of study are Plasmodium falciparum, Malaria, Artemisinin, Immunology and Drug resistance.
His work investigates the relationship between Plasmodium falciparum and topics such as Genetics that intersect with problems in Evolutionary biology and Mark and recapture.
His Malaria research includes elements of Internal medicine and Virology.
His studies deal with areas such as Combinatorial chemistry, Hemin, Biochemistry and Pharmacology as well as Artemisinin.
His Immunology research is multidisciplinary, incorporating elements of Transmission, Placenta and Acquired immunodeficiency syndrome.
His Drug resistance research focuses on subjects like Intensive care medicine, which are linked to Artesunate + mefloquine and Pharmacotherapy.
His most cited work include:
- Epidemiology of drug-resistant malaria. (708 citations)
- Artemisinin: mechanisms of action, resistance and toxicity. (491 citations)
- Artemisinin and the antimalarial endoperoxides: from herbal remedy to targeted chemotherapy. (461 citations)
What are the main themes of his work throughout his whole career to date?
His scientific interests lie mostly in Malaria, Plasmodium falciparum, Virology, Immunology and Artemisinin.
He interconnects Pregnancy, Internal medicine, Drug resistance and Environmental health in the investigation of issues within Malaria.
The Plasmodium falciparum study combines topics in areas such as Genetics, Genotype, Haplotype and Biochemistry.
His research in Virology intersects with topics in DHPS, Antigen, Dihydropteroate synthase, Antibody and Polymerase chain reaction.
His Immunology research incorporates themes from Placenta and Acquired immunodeficiency syndrome.
His studies deal with areas such as Stereochemistry, Pharmacology, Artesunate and Mechanism of action as well as Artemisinin.
He most often published in these fields:
- Malaria (43.75%)
- Plasmodium falciparum (39.95%)
- Virology (25.27%)
What were the highlights of his more recent work (between 2014-2021)?
- Malaria (43.75%)
- Plasmodium falciparum (39.95%)
- Virology (25.27%)
In recent papers he was focusing on the following fields of study:
Steven R. Meshnick focuses on Malaria, Plasmodium falciparum, Virology, Environmental health and Genetics.
His study in Malaria is interdisciplinary in nature, drawing from both Odds ratio and Pregnancy.
His Plasmodium falciparum study deals with the bigger picture of Immunology.
Within one scientific family, Steven R. Meshnick focuses on topics pertaining to Gametocyte under Virology, and may sometimes address concerns connected to Anopheles dirus.
His Environmental health research focuses on Public health and how it relates to Epidemiology and Transmission.
His work deals with themes such as Internal medicine and Pharmacology, which intersect with Artemisinin.
Between 2014 and 2021, his most popular works were:
- Absence of Putative Artemisinin Resistance Mutations Among Plasmodium falciparum in Sub-Saharan Africa: A Molecular Epidemiologic Study (196 citations)
- Dihydroartemisinin-piperaquine failure associated with a triple mutant including kelch13 C580Y in Cambodia: An observational cohort study (171 citations)
- Pfhrp2-Deleted Plasmodium falciparum Parasites in the Democratic Republic of the Congo: A National Cross-sectional Survey (67 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Internal medicine
- Malaria
Steven R. Meshnick mainly focuses on Malaria, Plasmodium falciparum, Genetics, Virology and Drug resistance.
His Malaria study incorporates themes from Internal medicine, Deep sequencing and Environmental health.
Steven R. Meshnick studies Sulfadoxine/pyrimethamine, a branch of Plasmodium falciparum.
His research in Virology intersects with topics in Gametocyte, Entomology and Incidence.
Steven R. Meshnick combines subjects such as Genotype, Allele frequency and Artemisinin with his study of Drug resistance.
Steven R. Meshnick has researched Artemisinin in several fields, including Ex vivo, Mefloquine and Pharmacology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
